Case report. High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

By de Jong D  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 573-575

Oxford University Press

Access to resources Recommend Favorite

Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist/follicle stimulating hormone ovulation induction for in-vitro fertilization

By Lass A  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3203-3205

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation

By CRongières-Bertrand  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 683-688

Oxford University Press

Access to resources Recommend Favorite

Cancer. Non-functioning pituitary tumour after long-term treatment with gonadotrophin-releasing hormone agonists in a patient with vaginal agenesis who underwent neovaginoplasty and cauterization of endometriosis under laparoscopy: Case Report

By Takai Yasushi  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2661-2664

Oxford University Press

Access to resources Recommend Favorite